RPL10P5

Across TCGA pan-cancer cohorts, RPL10P5 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPL10P5’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL10P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL10P5 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

COAD, KIRC, and PRAD are the cancer types where RPL10P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL10P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.326	<.001	6	view →
KIRC	All	All	+0.083	<.001	6	view →
PRAD	All	All	+0.112	.024	2	view →
HNSC	Male	All	+0.111	.047	2	view →
THCA	All	All	−0.069	.020	2	view →
LIHC	Female	All	+0.053	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RPL10P5–COAD

Open the COAD breakdown →